BC264 is a potent, selective CCK-B agonist capable of crossing the blood-brain barrier. It increases dopamine levels in the nucleus accumbens and enhances motivation and attention in rats.
Target:
Cholecystokinin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
